XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Oct. 30, 2021
Oct. 31, 2020
Cash flows from operating activities:    
Net loss $ (427,202) $ (293,834)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 189,677 149,922
Share-based compensation 325,922 182,060
Amortization of acquired intangible assets 684,593 333,934
Amortization of inventory fair value adjustment associated with acquisitions 191,030 17,284
Amortization of deferred debt issuance costs and debt discounts 19,031 3,217
Restructuring related impairment charges 5,205 123,559
Other expense, net 60,053 19,448
Deferred income taxes (67,570) 415
Changes in assets and liabilities, net of acquisition:    
Accounts receivable (341,444) 2,075
Prepaid expenses and other assets (65,339) (8,692)
Inventories (200,675) 29,817
Accounts payable 93,788 34,768
Accrued employee compensation 12,980 38,202
Accrued liabilities and other non-current liabilities (7,004) 26,817
Net cash provided by operating activities 473,045 658,992
Cash flows from investing activities:    
Purchases of technology licenses (9,371) (8,476)
Purchases of property and equipment (130,483) (88,242)
Acquisitions, net of cash acquired (3,539,729) 0
Other, net (2,457) 223
Net cash used in investing activities (3,682,040) (96,495)
Cash flows from financing activities:    
Repurchases of common stock 0 (25,202)
Proceeds from employee stock plans 42,784 50,490
Tax withholding paid on behalf of employees for net share settlement (169,001) (82,626)
Dividend payments to stockholders (140,318) (120,111)
Payments on technology license obligations (97,858) (76,794)
Proceeds from issuance of debt 3,806,096 0
Principal payments of debt (425,938) (100,000)
Payment for repurchases and settlement of convertible notes (181,207) 0
Proceeds from capped calls 160,319 0
Payment of equity and debt financing costs (11,850) (22,313)
Other, net 1,003 (1,504)
Net cash provided by (used in) financing activities 2,984,030 (378,060)
Net increase (decrease) in cash and cash equivalents (224,965) 184,437
Cash and cash equivalents at beginning of period 748,467 647,604
Cash and cash equivalents at end of period $ 523,502 $ 832,041